Cargando…

A Comprehensive Analysis of the PI3K/AKT Pathway: Unveiling Key Proteins and Therapeutic Targets for Cancer Treatment

BACKGROUND: Cancer development and progression involve a complex network of pathways among which certain pathways play a pivotal role in promoting tumor growth and survival. An important pathway in this context is the PI3K/AKT pathway, which regulates crucial cellular processes including proliferati...

Descripción completa

Detalles Bibliográficos
Autor principal:	Fadhal, Emad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462777/ https://www.ncbi.nlm.nih.gov/pubmed/37649725 http://dx.doi.org/10.1177/11769351231194273

Ejemplares similares

Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma
por: Tessiri, Supharada, et al.
Publicado: (2022)

Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
por: Barzegar Behrooz, Amir, et al.
Publicado: (2022)

Targeting AKT1-E17K and the PI3K/AKT Pathway with an Allosteric AKT Inhibitor, ARQ 092
por: Yu, Yi, et al.
Publicado: (2015)

Modelling human protein interaction networks as metric spaces has potential in disease research and drug target discovery
por: Fadhal, Emad, et al.
Publicado: (2014)

Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway
por: Adimonye, Anthony, et al.
Publicado: (2018)

PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
por: Liu, Rui, et al.
Publicado: (2020)

The PI3K/AKT Pathway—The Potential Key Mechanisms of Traditional Chinese Medicine for Stroke
por: Gu, Chenyang, et al.
Publicado: (2022)

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: TIAN, FENG, et al.
Publicado: (2015)

Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells
por: Tian, Feng, et al.
Publicado: (2023)

Molecular Alterations of PI3K/Akt/mTOR Pathway: A Therapeutic Target in Endometrial Cancer
por: Pavlidou, Athanasia, et al.
Publicado: (2014)

Computer-Aided Targeting of the PI3K/Akt/mTOR Pathway: Toxicity Reduction and Therapeutic Opportunities
por: Li, Tan, et al.
Publicado: (2014)

Targeting the PI3K/Akt/mTOR pathway: A therapeutic strategy in COVID-19 patients
por: Abu-Eid, Rasha, et al.
Publicado: (2021)

Mutational Landscape of PI3K-AKT-mTOR Pathway in Breast Cancer: Implications for Targeted Therapeutics
por: Xiao, Weikai, et al.
Publicado: (2021)

Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics
por: Costa, Céu, et al.
Publicado: (2015)

Targeting the PI3K/Akt/mTOR Pathway – Beyond Rapalogs
por: Markman, Ben, et al.
Publicado: (2010)

Targeting the PI3K/AKT/MTOR pathway in KSHV-associated cancers
por: Bhatt, A, et al.
Publicado: (2009)

Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
por: Sun, Eun Jin, et al.
Publicado: (2021)

Therapeutic targets for cancer: Current concepts with PI 3-K, Akt, & mTOR
por: Maiese, Kenneth
Publicado: (2013)

PI3K/AKT Pathway and Brain Malformations
por: Rice, Gavin B., et al.
Publicado: (2015)

The PI3K/Akt Pathway in Meta-Inflammation
por: Acosta-Martinez, Maricedes, et al.
Publicado: (2022)

Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathway
por: Presneau, N, et al.
Publicado: (2009)

PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics
por: Ghoneum, Alia, et al.
Publicado: (2019)

Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile Cancer
por: Thomas, Anita, et al.
Publicado: (2021)

HijAkt: The PI3K/Akt Pathway in Virus Replication and Pathogenesis
por: Dunn, Ewan F., et al.
Publicado: (2012)

Self-similarity of human protein interaction networks: a novel strategy of distinguishing proteins
por: Fadhal, Emad, et al.
Publicado: (2015)

The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges
por: Cheaib, Bianca, et al.
Publicado: (2015)

Roles of PI3K/AKT/PTEN Pathway as a Target for Pharmaceutical Therapy
por: Matsuda, Satoru, et al.
Publicado: (2013)

PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
por: Li, Xiaoman, et al.
Publicado: (2016)

Targeting the PI3K/Akt/mTOR signalling pathway in Cystic Fibrosis
por: Reilly, R., et al.
Publicado: (2017)

Quercetin alleviates chronic renal failure by targeting the PI3k/Akt pathway
por: Tu, Haitao, et al.
Publicado: (2021)

Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
por: Li, Huayi, et al.
Publicado: (2021)

Therapeutic Priority of the PI3K/AKT/mTOR Pathway in Small Cell Lung Cancers as Revealed by a Comprehensive Genomic Analysis
por: Umemura, Shigeki, et al.
Publicado: (2014)

Targeting the PI3K/AKT/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer
por: Rinne, Natasha, et al.
Publicado: (2021)

Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis
por: Wang, Jincheng, et al.
Publicado: (2022)

Unveiling Therapeutic Targets for Esophageal Cancer: A Comprehensive Review
por: Acharya, Rakesh, et al.
Publicado: (2023)

PI3K/AKT/mTOR Pathway in Angiogenesis
por: Karar, Jayashree, et al.
Publicado: (2011)

The PI3K/Akt Pathway in Tumors of Endocrine Tissues
por: Robbins, Helen Louise, et al.
Publicado: (2016)

Modulation of telomere protection by the PI3K/AKT pathway
por: Méndez-Pertuz, Marinela, et al.
Publicado: (2017)

The effects of Ginsenosides on PI3K/AKT signaling pathway
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

Inhibition of Axl Promotes the Therapeutic Effect of Targeted Inhibition of the PI3K/Akt Pathway in NRAS Mutant Melanoma Cells
por: Gao, Xuejun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r6ughq8ch3g8lan015b6rm5n9k